Revisión retrospectiva de historias clínicas para evaluar el perfil de seguridad del ceftobiprol en pacientes con insuficiencia hepática o renal o inmunosupresión.
Datos básicos
- Protocolo:
- RETRACE BPR-PAS-001
- EUDRACT:
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Año de incio:
- 2023
- Año de finalización:
- 2023
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
ADVANZ PHARMA SWITZERLAND SÁRL
Resultados del Ensayo Clínico
Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients.
González J; (...); Barbé F
Article. 10.1016/j.arbres.2022.12.017. 2023
Long-term Mortality in COVID-19 and Community-Acquired Pneumonia: A One-year Follow-up Study
Ocana, R. Mendez; (...); NEUMONAC RECOVID
Meeting Abstract. 2023
Neutrophil Extracellular Traps and Platelet Activation for Identifying Severe Episodes and Clinical Trajectories in COVID-19
González-Jiménez P; (...); Menéndez R
Article. 10.3390/ijms24076690. 2023
Residual pulmonary infiltrates, symptoms and diffusion impairment at one-year after severe COVID-19 infection have different associated factors.
Menendez, Rosario; (...); Torres, Antoni
Article. 10.1111/joim.13642. 2023
The U-Shaped Relationship Between Eosinophil Count and Bronchiectasis Severity: The Effect of Inhaled Corticosteroids.
Martinez-Garcia, Miguel Angel; (...); de la Rosa, David
Article. 10.1016/j.chest.2023.04.029. 2023
Validation of IDSA/ATS Guidelines for ICU Admission in Adults Over 80 Years Old With Community-Acquired Pneumonia.
Cilloniz, Catia; (...); Torres, Antoni
Article. 10.1016/j.arbres.2022.08.012. 2023